Minireviews
Copyright ©The Author(s) 2015.
World J Virology. Nov 12, 2015; 4(4): 356-364
Published online Nov 12, 2015. doi: 10.5501/wjv.v4.i4.356
Figure 1
Figure 1 Schematic explanation for the model (1) showing the effect of high drug levels.
Math 1
Math 1 Math(A1).
Math 2
Math 2 Math(A1).
Math 3
Math 3 Math(A1).
Math 4
Math 4 Math(A1).
Math 5
Math 5 Math(A1).
Math 6
Math 6 Math(A1).
Math 7
Math 7 Math(A1).
Math 8
Math 8 Math(A1).
Math 9
Math 9 Math(A1).
Math 10
Math 10 Math(A1).
Math 11
Math 11 Math(A1).
Math 12
Math 12 Math(A1).
Math 13
Math 13 Math(A1).
Math 14
Math 14 Math(A1).
Math 15
Math 15 Math(A1).
Math 16
Math 16 Math(A1).
Math 17
Math 17 Math(A1).
Math 18
Math 18 Math(A1).
Math 19
Math 19 Math(A1).
Math 20
Math 20 Math(A1).
Math 21
Math 21 Math(A1).
Math 22
Math 22 Math(A1).
Math 23
Math 23 Math(A1).
Figure 2
Figure 2 Trajectories showing the concentration changes with time of the model variable under restrained antibody vaccination with A bar = 0. 5 and A = 100.
Math 24
Math 24 Math(A1).
Figure 3
Figure 3 Trajectories showing the concentration changes with time of the model variable under different antibody vaccination concentration with τ = 0. 5.
Figure 4
Figure 4 Trajectories showing the concentration changes with time of the model variable under restrained antibody vaccination with τ = 0. 5 along with drug holidays for a period of 30 d.
Figure 5
Figure 5 Trajectories showing the concentration changes with time of the model variable under restrained antibody vaccination with τ = 0. 5 along with drug holidays for a period of 10 d.
Figure 6
Figure 6 Phase plane showing the concentration of antibody responses against fixed dosing interval.